Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV study of ritonavir dose optimization and simplification in tipranavir-containing salvage therapy
2006-006041-13Phase 4Active
- Sponsor
- Ramón y Cajal University Hospital
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ritonavir and tipranavir in Human immunodeficiency virus infection type 1, sponsored by Ramón y Cajal University Hospital. Primary endpoint: Proportion of patients with undetectable viral load at 48 weeks. Started Feb 2007; status: active.
02
Drugs
ritonavirtipranavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2006-006041-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006041-13.